Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

NCT02439489 is registered in ClinicalTrials.gov with Fondazione Michelangelo as lead sponsor.

NCT NCT02439489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02439489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors
Lead sponsor
Fondazione Michelangelo
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2017
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors